We are at the GfV 2025

Members of the APPEAL consortium will present some results in 1 talk and 2 poster at the 34th Annual Meeting of the Society for Virology (GfV Meeting, 4-7.03.25 Hamburg, Germany, https://virology-meeting.de/)
Talk:
Title: Investigating host dependency factor screening data across haemorhagic fever and respiratory viruses to identify communalities and differences using machine learning
Authors: Alicia Hiemisch, Mohadeseh Naseri, Andre Dietz, Rainer König
Affiliation: Jena University Hospital, Institute for Infectious Diseases and Infection Control, Jena, Germany
Day/Time: 5.03.25 (13:30-13:45 PM), Session system virology
Posters:
Title: The β-catenin/CREB-binding protein (CBP) inhibitor PRI-724 acts as a broad-spectrum antiviral in in vitro and ex vivo model systems
Authors: Maximilian A. Kelch1, Jeremy Sousa1, Alicia Hiemisch2, Denisa Bojkova1, Rainer König2, Tuna Toptan3
Affiliation: 1 Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt,Frankfurt, Germany
2 Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
3 Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Day/Time: P 063 - 04.03.25 (13:30 – 18:00 PM), Session: Antiviral therapy and resistance
Title: RSV Treatment Beyond Direct Antivirals: Exploring and interfering the Host gene regulatory response for Potential Targets for Therapeutic Intervention
Authors: F. D. Keogh, A. Dietz1, Rainer König
Affiliation: Jena University Hospital, Jena, Germany
Day/Time: P 240 - 06.03.25 (8:30 AM – 18:00 PM), Session System virology,
Talk:
Title: Investigating host dependency factor screening data across haemorhagic fever and respiratory viruses to identify communalities and differences using machine learning
Authors: Alicia Hiemisch, Mohadeseh Naseri, Andre Dietz, Rainer König
Affiliation: Jena University Hospital, Institute for Infectious Diseases and Infection Control, Jena, Germany
Day/Time: 5.03.25 (13:30-13:45 PM), Session system virology
Posters:
Title: The β-catenin/CREB-binding protein (CBP) inhibitor PRI-724 acts as a broad-spectrum antiviral in in vitro and ex vivo model systems
Authors: Maximilian A. Kelch1, Jeremy Sousa1, Alicia Hiemisch2, Denisa Bojkova1, Rainer König2, Tuna Toptan3
Affiliation: 1 Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt,Frankfurt, Germany
2 Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
3 Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Day/Time: P 063 - 04.03.25 (13:30 – 18:00 PM), Session: Antiviral therapy and resistance
Title: RSV Treatment Beyond Direct Antivirals: Exploring and interfering the Host gene regulatory response for Potential Targets for Therapeutic Intervention
Authors: F. D. Keogh, A. Dietz1, Rainer König
Affiliation: Jena University Hospital, Jena, Germany
Day/Time: P 240 - 06.03.25 (8:30 AM – 18:00 PM), Session System virology,